The pharmaceutical landscape is witnessing a development with the introduction of GLP-1 transdermal systems . These cutting-edge formulations offer a promising alternative to delivering glucagon-like peptide-1 medication for individuals managing type 2 diabetes . Instead of injections , a conveni